Two women died amid heavy rain in Tamil Nadu's Cuddalore after a building collapsed. The state is bracing for more rain, with a well-marked low pressure area over the Bay of Bengal likely to cross its ...

Madurai: With tech giant Google choosing neighbouring Andhra Pradesh for a USD 15 bn data hub project, the AIADMK in Tamil Nadu on Tuesday took a swipe at the ruling DMK's investments initiatives, ...

The Supreme Court expressed concern over child deaths in Madhya Pradesh due to contaminated cough syrup but refused to monitor a probe. Solicitor general Tushar Mehta intervened, stating states are ...

"Curb Your Enthusiasm" actress Cheryl Hines clashed with co-hosts of "The View" and defended her husband, Health and Human Services Secretary Robert F. Kennedy Jr. On Tuesday, during a discussion of ...

Hines joined The View to promote her new memoir, Cheryl Hines Unscripted, and it did not take long for her husband to become the topic of conversation. Kennedy and his views on health, including his ...

Malayalam superstar Dulquer Salmaan's house and over a dozen locations across South India were raided by the Enforcement Directorate amid a probe into smuggling cartels illegally importing high-end ...

Innoven Capital-backed Niro has shut down, its co-founder, Aditya Kumar, said on LinkedIn. The company, which helped consumer internet platforms offer financial products such as loans to users, had ...

IT giant HCL Tech has announced its plan to change its quarterly variable pay policy to fixed salaries for all employees and roll out salary increments from October, following last year's process. “We ...

Rep. Marjorie Taylor Greene, R-Ga., and the liberal media are mutual antagonists, but on Thursday, she earned praise from two unexpected places: CNN and "The View." "She seems to be the only one ...

If your feed isn’t already filled with AI-generated video slop, it’s only a matter of time. Meta and OpenAI will make sure of it. Meta recently announced its endless slop-feed Vibes, made up entirely ...

Investing.com -- Tvardi Therapeutics (NASDAQ:TVRD) stock plunged 30% after the company reported disappointing preliminary data from its Phase 2 REVERT trial evaluating TTI-101 in idiopathic pulmonary ...